Advanced Statistical Designs to Empower Biomarker-driven Clinical Trials: Promoting the use of efficient statistical methods in practice
29 April 2024, 9.00 AM - 1 May 2024, 5.00 PM
Bath Royal Literary and Scientific Institution
Improving Design and analysis of oncology trials Evaluating New targeted Therapies (IDENT) Research Dissemination Workshop
The paradigm of drug development in oncology has been revolutionised due to advances in genomic technology. Patients can now be stratified into small subgroups that may receive different benefits from a new treatment, using biomarker information (e.g., measurements of characteristic biological properties or genetic aberration). This has brought a paradigm shift from the one-size-fits-all approach towards precision medicine.
Many innovative statistical designs and analysis strategies, with some going beyond oncology areas, have been developed over the past two decades. Yet there is limited uptake of such methods in practical implementation. This workshop will include (1) a full-day short course to introduce some key concepts and innovative statistical methodology, and (2) a two-day workshop that consists of research talks given by prominent scholars in the field.